APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-Term Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long-Term Asthma Drugs Market Analysis and Forecast 2026-2032

31 December 2025199 pages

Choose your research edition.

Industry ResearchLong-Term Asthma Drugs Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-Term Asthma Drugs Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Long-Term Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-Term Asthma Drugs Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-Term Asthma Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Long-Term Asthma Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Long-Term Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long-Term Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long-Term Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long-Term Asthma Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Long-Term Asthma Drugs include Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group, Teva Pharmaceutical and Boehringer Ingelheim, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Long-Term Asthma Drugs, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long-Term Asthma Drugs, also provides the revenue of main regions and countries. Of the upcoming market potential for Long-Term Asthma Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-Term Asthma Drugs revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-Term Asthma Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Long-Term Asthma Drugs revenue, projected growth trends, production technology, application and end-user industry.

Long-Term Asthma Drugs Segment by Company

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Teva Pharmaceutical

Boehringer Ingelheim

Long-Term Asthma Drugs Segment by Type

Tablet

Spray

Long-Term Asthma Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Long-Term Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-Term Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-Term Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-Term Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Long-Term Asthma Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Long-Term Asthma Drugs company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-Term Asthma Drugs revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-Term Asthma Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tablet Major Player Table 3. Spray Major Player Table 4. Global Long-Term Asthma Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Player Table 6. Online Pharmacy Major Player Table 7. Hospital Pharmacy Major Player Table 8. Long-Term Asthma Drugs Industry Trends Table 9. Long-Term Asthma Drugs Industry Drivers Table 10. Long-Term Asthma Drugs Industry Opportunities and Challenges Table 11. Long-Term Asthma Drugs Industry Restraints Table 12. Global Long-Term Asthma Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Long-Term Asthma Drugs Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Long-Term Asthma Drugs Market Share by Region (2021-2026) Table 15. Global Long-Term Asthma Drugs Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Long-Term Asthma Drugs Market Share by Region (2027-2032) Table 17. Global Long-Term Asthma Drugs Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Long-Term Asthma Drugs Revenue Market Share by Players (2021-2026) Table 19. Global Long-Term Asthma Drugs Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Long-Term Asthma Drugs Key Players Headquarters & Area Served Table 21. Global Long-Term Asthma Drugs Players, Product Type & Application Table 22. Global Long-Term Asthma Drugs Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Long-Term Asthma Drugs by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Long-Term Asthma Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Long-Term Asthma Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Long-Term Asthma Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Long-Term Asthma Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Long-Term Asthma Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Long-Term Asthma Drugs Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Long-Term Asthma Drugs Product Portfolio Table 39. Novartis Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Long-Term Asthma Drugs Product Portfolio Table 44. Merck Recent Development Table 45. Roche Company Information Table 46. Roche Business Overview Table 47. Roche Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Roche Long-Term Asthma Drugs Product Portfolio Table 49. Roche Recent Development Table 50. Pfizer Company Information Table 51. Pfizer Business Overview Table 52. Pfizer Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Pfizer Long-Term Asthma Drugs Product Portfolio Table 54. Pfizer Recent Development Table 55. GlaxoSmithKline Company Information Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. GlaxoSmithKline Long-Term Asthma Drugs Product Portfolio Table 59. GlaxoSmithKline Recent Development Table 60. AstraZeneca Company Information Table 61. AstraZeneca Business Overview Table 62. AstraZeneca Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. AstraZeneca Long-Term Asthma Drugs Product Portfolio Table 64. AstraZeneca Recent Development Table 65. Vectura Group Company Information Table 66. Vectura Group Business Overview Table 67. Vectura Group Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Vectura Group Long-Term Asthma Drugs Product Portfolio Table 69. Vectura Group Recent Development Table 70. Teva Pharmaceutical Company Information Table 71. Teva Pharmaceutical Business Overview Table 72. Teva Pharmaceutical Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Teva Pharmaceutical Long-Term Asthma Drugs Product Portfolio Table 74. Teva Pharmaceutical Recent Development Table 75. Boehringer Ingelheim Company Information Table 76. Boehringer Ingelheim Business Overview Table 77. Boehringer Ingelheim Long-Term Asthma Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Boehringer Ingelheim Long-Term Asthma Drugs Product Portfolio Table 79. Boehringer Ingelheim Recent Development Table 80. North America Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 81. North America Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 82. North America Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Long-Term Asthma Drugs Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Long-Term Asthma Drugs Revenue by Country (US$ Million) & (2027-2032) Table 87. Europe Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 88. Europe Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 89. Europe Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 90. Europe Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 91. Europe Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Europe Long-Term Asthma Drugs Revenue by Country (2021-2026) & (US$ Million) Table 93. Europe Long-Term Asthma Drugs Revenue by Country (US$ Million) & (2027-2032) Table 94. China Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 95. China Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 96. China Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 97. China Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 98. Asia Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 99. Asia Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 100. Asia Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 101. Asia Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Long-Term Asthma Drugs Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Asia Long-Term Asthma Drugs Revenue by Region (US$ Million) & (2021-2026) Table 104. Asia Long-Term Asthma Drugs Revenue by Region (US$ Million) & (2027-2032) Table 105. SAMEA Long-Term Asthma Drugs Revenue by Type (2021-2026) & (US$ Million) Table 106. SAMEA Long-Term Asthma Drugs Revenue by Type (2027-2032) & (US$ Million) Table 107. SAMEA Long-Term Asthma Drugs Revenue by Application (2021-2026) & (US$ Million) Table 108. SAMEA Long-Term Asthma Drugs Revenue by Application (2027-2032) & (US$ Million) Table 109. SAMEA Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. SAMEA Long-Term Asthma Drugs Revenue by Country (2021-2026) & (US$ Million) Table 111. SAMEA Long-Term Asthma Drugs Revenue by Country (US$ Million) & (2027-2032) Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Long-Term Asthma Drugs Image Figure 2. Global Long-Term Asthma Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-Term Asthma Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablet Image Figure 5. Spray Image Figure 6. Global Long-Term Asthma Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Long-Term Asthma Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Long-Term Asthma Drugs Market Size (US$ Million) & (2021-2032) Figure 12. Global Long-Term Asthma Drugs Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Long-Term Asthma Drugs Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Long-Term Asthma Drugs Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Long-Term Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Long-Term Asthma Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Long-Term Asthma Drugs Revenue Market Share by Type (2021-2032) Figure 19. Global Long-Term Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Long-Term Asthma Drugs Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Long-Term Asthma Drugs Revenue Market Share by Application (2021-2032) Figure 22. North America Long-Term Asthma Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Long-Term Asthma Drugs Revenue Share by Type (2021-2032) Figure 24. North America Long-Term Asthma Drugs Revenue Share by Application (2021-2032) Figure 25. North America Long-Term Asthma Drugs Revenue Share by Country (2021-2032) Figure 26. United States Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Long-Term Asthma Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Long-Term Asthma Drugs Revenue Share by Type (2021-2032) Figure 31. Europe Long-Term Asthma Drugs Revenue Share by Application (2021-2032) Figure 32. Europe Long-Term Asthma Drugs Revenue Share by Country (2021-2032) Figure 33. Germany Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Long-Term Asthma Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Long-Term Asthma Drugs Revenue Share by Type (2021-2032) Figure 43. China Long-Term Asthma Drugs Revenue Share by Application (2021-2032) Figure 44. Asia Long-Term Asthma Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Long-Term Asthma Drugs Revenue Share by Type (2021-2032) Figure 46. Asia Long-Term Asthma Drugs Revenue Share by Application (2021-2032) Figure 47. Asia Long-Term Asthma Drugs Revenue Share by Region (2021-2032) Figure 48. Japan Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Long-Term Asthma Drugs Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Long-Term Asthma Drugs Revenue Share by Type (2021-2032) Figure 56. SAMEA Long-Term Asthma Drugs Revenue Share by Application (2021-2032) Figure 57. SAMEA Long-Term Asthma Drugs Revenue Share by Country (2021-2032) Figure 58. Brazil Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Long-Term Asthma Drugs Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Spray
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Teva Pharmaceutical
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long-Term Asthma Drugs Market by Type
  3. 1.2.1 Global Long-Term Asthma Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tablet
  5. 1.2.3 Spray
  6. 1.3 Long-Term Asthma Drugs Market by Application
  7. 1.3.1 Global Long-Term Asthma Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Long-Term Asthma Drugs Market Dynamics
  1. 2.1 Long-Term Asthma Drugs Industry Trends
  2. 2.2 Long-Term Asthma Drugs Industry Drivers
  3. 2.3 Long-Term Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Long-Term Asthma Drugs Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Long-Term Asthma Drugs Market Perspective (2021-2032)
  2. 3.2 Global Long-Term Asthma Drugs Growth Trends by Region
  3. 3.2.1 Global Long-Term Asthma Drugs Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long-Term Asthma Drugs Market Size by Region (2021-2026)
  5. 3.2.3 Global Long-Term Asthma Drugs Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Long-Term Asthma Drugs Revenue by Players
  2. 4.1.1 Global Long-Term Asthma Drugs Revenue by Players (2021-2026)
  3. 4.1.2 Global Long-Term Asthma Drugs Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Long-Term Asthma Drugs Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long-Term Asthma Drugs Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Long-Term Asthma Drugs Key Players Headquarters & Area Served
  7. 4.4 Global Long-Term Asthma Drugs Players, Product Type & Application
  8. 4.5 Global Long-Term Asthma Drugs Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Long-Term Asthma Drugs Market CR5 and HHI
  11. 4.6.3 2025 Long-Term Asthma Drugs Tier 1, Tier 2, and Tier 3
5 Long-Term Asthma Drugs Market Size by Type
  1. 5.1 Global Long-Term Asthma Drugs Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 5.3 Global Long-Term Asthma Drugs Revenue Market Share by Type (2021-2032)
6 Long-Term Asthma Drugs Market Size by Application
  1. 6.1 Global Long-Term Asthma Drugs Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Long-Term Asthma Drugs Revenue by Application (2021-2032)
  3. 6.3 Global Long-Term Asthma Drugs Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Long-Term Asthma Drugs Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck Long-Term Asthma Drugs Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Long-Term Asthma Drugs Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Long-Term Asthma Drugs Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Long-Term Asthma Drugs Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 AstraZeneca
  32. 7.6.1 AstraZeneca Company Information
  33. 7.6.2 AstraZeneca Business Overview
  34. 7.6.3 AstraZeneca Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AstraZeneca Long-Term Asthma Drugs Product Portfolio
  36. 7.6.5 AstraZeneca Recent Developments
  37. 7.7 Vectura Group
  38. 7.7.1 Vectura Group Company Information
  39. 7.7.2 Vectura Group Business Overview
  40. 7.7.3 Vectura Group Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Vectura Group Long-Term Asthma Drugs Product Portfolio
  42. 7.7.5 Vectura Group Recent Developments
  43. 7.8 Teva Pharmaceutical
  44. 7.8.1 Teva Pharmaceutical Company Information
  45. 7.8.2 Teva Pharmaceutical Business Overview
  46. 7.8.3 Teva Pharmaceutical Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Teva Pharmaceutical Long-Term Asthma Drugs Product Portfolio
  48. 7.8.5 Teva Pharmaceutical Recent Developments
  49. 7.9 Boehringer Ingelheim
  50. 7.9.1 Boehringer Ingelheim Company Information
  51. 7.9.2 Boehringer Ingelheim Business Overview
  52. 7.9.3 Boehringer Ingelheim Long-Term Asthma Drugs Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Boehringer Ingelheim Long-Term Asthma Drugs Product Portfolio
  54. 7.9.5 Boehringer Ingelheim Recent Developments
8 North America
  1. 8.1 North America Long-Term Asthma Drugs Revenue (2021-2032)
  2. 8.2 North America Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 8.2.1 North America Long-Term Asthma Drugs Revenue by Type (2021-2026)
  4. 8.2.2 North America Long-Term Asthma Drugs Revenue by Type (2027-2032)
  5. 8.3 North America Long-Term Asthma Drugs Revenue Share by Type (2021-2032)
  6. 8.4 North America Long-Term Asthma Drugs Revenue by Application (2021-2032)
  7. 8.4.1 North America Long-Term Asthma Drugs Revenue by Application (2021-2026)
  8. 8.4.2 North America Long-Term Asthma Drugs Revenue by Application (2027-2032)
  9. 8.5 North America Long-Term Asthma Drugs Revenue Share by Application (2021-2032)
  10. 8.6 North America Long-Term Asthma Drugs Revenue by Country
  11. 8.6.1 North America Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Long-Term Asthma Drugs Revenue by Country (2021-2026)
  13. 8.6.3 North America Long-Term Asthma Drugs Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Long-Term Asthma Drugs Revenue (2021-2032)
  2. 9.2 Europe Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 9.2.1 Europe Long-Term Asthma Drugs Revenue by Type (2021-2026)
  4. 9.2.2 Europe Long-Term Asthma Drugs Revenue by Type (2027-2032)
  5. 9.3 Europe Long-Term Asthma Drugs Revenue Share by Type (2021-2032)
  6. 9.4 Europe Long-Term Asthma Drugs Revenue by Application (2021-2032)
  7. 9.4.1 Europe Long-Term Asthma Drugs Revenue by Application (2021-2026)
  8. 9.4.2 Europe Long-Term Asthma Drugs Revenue by Application (2027-2032)
  9. 9.5 Europe Long-Term Asthma Drugs Revenue Share by Application (2021-2032)
  10. 9.6 Europe Long-Term Asthma Drugs Revenue by Country
  11. 9.6.1 Europe Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Long-Term Asthma Drugs Revenue by Country (2021-2026)
  13. 9.6.3 Europe Long-Term Asthma Drugs Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Long-Term Asthma Drugs Revenue (2021-2032)
  2. 10.2 China Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 10.2.1 China Long-Term Asthma Drugs Revenue by Type (2021-2026)
  4. 10.2.2 China Long-Term Asthma Drugs Revenue by Type (2027-2032)
  5. 10.3 China Long-Term Asthma Drugs Revenue Share by Type (2021-2032)
  6. 10.4 China Long-Term Asthma Drugs Revenue by Application (2021-2032)
  7. 10.4.1 China Long-Term Asthma Drugs Revenue by Application (2021-2026)
  8. 10.4.2 China Long-Term Asthma Drugs Revenue by Application (2027-2032)
  9. 10.5 China Long-Term Asthma Drugs Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long-Term Asthma Drugs Revenue (2021-2032)
  2. 11.2 Asia Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 11.2.1 Asia Long-Term Asthma Drugs Revenue by Type (2021-2026)
  4. 11.2.2 Asia Long-Term Asthma Drugs Revenue by Type (2027-2032)
  5. 11.3 Asia Long-Term Asthma Drugs Revenue Share by Type (2021-2032)
  6. 11.4 Asia Long-Term Asthma Drugs Revenue by Application (2021-2032)
  7. 11.4.1 Asia Long-Term Asthma Drugs Revenue by Application (2021-2026)
  8. 11.4.2 Asia Long-Term Asthma Drugs Revenue by Application (2027-2032)
  9. 11.5 Asia Long-Term Asthma Drugs Revenue Share by Application (2021-2032)
  10. 11.6 Asia Long-Term Asthma Drugs Revenue by Country
  11. 11.6.1 Asia Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Long-Term Asthma Drugs Revenue by Country (2021-2026)
  13. 11.6.3 Asia Long-Term Asthma Drugs Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long-Term Asthma Drugs Revenue (2021-2032)
  2. 12.2 SAMEA Long-Term Asthma Drugs Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Long-Term Asthma Drugs Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Long-Term Asthma Drugs Revenue by Type (2027-2032)
  5. 12.3 SAMEA Long-Term Asthma Drugs Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Long-Term Asthma Drugs Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Long-Term Asthma Drugs Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Long-Term Asthma Drugs Revenue by Application (2027-2032)
  9. 12.5 SAMEA Long-Term Asthma Drugs Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Long-Term Asthma Drugs Revenue by Country
  11. 12.6.1 SAMEA Long-Term Asthma Drugs Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Long-Term Asthma Drugs Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Long-Term Asthma Drugs Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst